Skip to main content
. 2018 May 29;10:51. doi: 10.1186/s13195-018-0379-6

Table 2.

Patent information for the drugs used for dementia [21]

Generic name Patent name (manufacturer) Drug class Patent expiry
Donepezil Aricept (Eisai  / Pfizer) AChE inhibitor January 2012
Rivastigmine Exelon (Novartis) AChE inhibitor February 2012
Galantamine Reminyl (Shire) AChE inhibitor July 2012
Memantine Ebixa (Lundbeck) NMDA receptor antagonist April 2014

AChE Acetylcholinesterase, NMDA N-methyl-d-aspartate